Healthcare workers’ willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo

References

• Chi WY, Li Y-D, Huang H-C, Chan TEH, Chow S-Y, Su J-H, Ferrall L, Hung C-F, Wu T-C. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci. 2022;29(1):1–9. doi:10.1186/s12929-022-00853-8.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Siaw Y-L, Muslimin M, Lai LL, Lin Y, Hu Z. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia. Hum Vaccines Immunother. 2022;18(5). doi:10.1080/21645515.2022.2078634.
   Web of Science ®Google Scholar
• A S, Mohsina Haq NUH, Rehman A, Haq M, Haq H, Rajab H, Ahmad J, Ahmed J, Anwar S. Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19. Ther Adv Vaccines. 2022;10:1–7. doi:10.1177/25151355221080724.
   Google Scholar
• Shui X, Wang F, Li L, Liang Q. COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis. PLOS ONE. 2022;17(8 August):73–83. doi:10.1371/journal.pone.0273112.
   Web of Science ®Google Scholar
• Desye B. Prevalence and determinants of COVID-19 vaccine acceptance among healthcare workers: a systematic review. Front Public Health. 2021;10(September):1–7. 2022. doi:10.3389/fpubh.2022.941206.
   Google Scholar
• Adane M, Ademas A, Kloos H. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia. BMC Public Health. 2022;22(1):1–14. doi:10.1186/s12889-021-12362-8.
   PubMed Web of Science ®Google Scholar
• Pooley N, Abdool Karim SS, Combadière B, Ooi EE, Harris RC, El Guerche Seblain C, Kisomi M, Shaikh N. Durability of vaccine-induced and natural immunity against COVID-19: a narrative review. Infect Dis Ther. 2023;12(2):367–87. doi:10.1007/s40121-022-00753-2.
   PubMed Web of Science ®Google Scholar
• Townsend JP, Hassler HB, Sah P, Galvani AP, Dornburg A. The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2. Proc Natl Acad Sci USA. 2022;119(31):1–8. doi:10.1073/pnas.2204336119.
   Web of Science ®Google Scholar
• Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O’Brien KL, Smith PG. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924–44. doi:10.1016/S0140-6736(22)00152-0.
   PubMed Web of Science ®Google Scholar
• Adams K, Rhoads, JP, Surie D, Gaglani M, Ginde, AA, McNeal T, Talbot, HK, Casey, JD, Zepeski A, Shapiro, NI. et al. Vaccine effectiveness of primary series and booster doses against COVID-19 associated hospital admissions in the United States: Living test negative design study. BMJ. 2022;11:1–15. doi:10.1136/bmj-2022-072065.
   Google Scholar
• Zola Matuvanga T, Doshi RH, Muya A, Cikomola A, Milabyo A, Nasaka P, Mitashi P, Muhindo-Mavoko H, Ahuka S, Nzaji M. et al. Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo–a commentary. Hum Vaccines Immunother. 2022;18(6). doi:10.1080/21645515.2022.2127272.
   PubMed Web of Science ®Google Scholar
• Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur VP, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A. et al. SARS-CoV-2 reinfection rate and estimated effectiveness of the inactivated whole virion vaccine BBV152 against reinfection among health care workers in New Delhi, India. JAMA Netw Open. 2022;5(1):1–14. doi:10.1001/jamanetworkopen.2021.42210.
   Web of Science ®Google Scholar
• Ward H, Whitaker M, Flower B, Tang SN, Atchison C, Darzi A, Donnelly CA, Cann A, Diggle PJ, Ashby D. et al. Population antibody responses following COVID-19 vaccination in 212,102 individuals. Nat Commun. 2022;13(1):1–6. doi:10.1038/s41467-022-28527-x.
   PubMed Web of Science ®Google Scholar
• Mizrahi B, Lotan R, Kalkstein N, Peretz A, Perez G, Ben-Tov A, Chodick G, Gazit S, Patalon T. Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun. 2021;12(1):1–5. doi:10.1038/s41467-021-26672-3.
   PubMed Web of Science ®Google Scholar
• Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121–6. doi:10.4103/0253-7176.116232.
   PubMedGoogle Scholar
• Delwer M, Hawlader H, Lutfor M, Nazir A. COVID-19 vaccine acceptance in South Asia: a multi-country study. Int J Infect Dis. 2020;114:1–0.
   Web of Science ®Google Scholar
• Vellappally S, Naik S, Alsadon O, Al-Kheraif AA, Alayadi H, Alsiwat AJ, Kumar A, Hashem M, Varghese N, Thomas NG. et al. Perception of COVID-19 booster dose vaccine among healthcare workers in India and Saudi Arabia. Int J Environl Res Public Health. 2022;19(15):1–11. doi:10.3390/ijerph19158942.
   Web of Science ®Google Scholar
• Alhasan K, Aljamaan F, Temsah, MH, Alshahrani F, Bassrawi R, Alhaboob A, Assiri R, Alenezi S, Alaraj A, Alhomoudi, RI. et al. Covid-19 delta variant: Perceptions, worries, and vaccine-booster acceptability among healthcare workers. Healthcare. 2021;9(11):1–19. doi:10.3390/healthcare9111566.
   Web of Science ®Google Scholar
• Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, Hooda D, Khan R, Arora S, Singh A. et al. Assessing COVID-19 booster hesitancy and its correlates: an early evidence from India. Nato Adv Sci Inst Se. 2022;10(7):1–13. doi:10.3390/vaccines10071048.
   Google Scholar
• Abouzid M, Ahmed AA, El-Sherif DM, Alonazi WB, Eatmann AI, Alshehri MM, Saleh RN, Ahmed MH, Aziz IA, Abdelslam AE. et al. Attitudes toward receiving COVID-19 booster dose in the Middle East and North Africa (MENA) region: a cross-sectional study of 3041 fully vaccinated participants. Nato Adv Sci Inst Se. 2022;10(8):1270. doi:10.3390/vaccines10081270.
   Google Scholar
• Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in czechia: national cross-sectional study. Nato Adv Sci Inst Se. 2021;9(12):1–29. doi:10.3390/vaccines9121437.
   Google Scholar
• Luo C, Chen HX, Tung TH. COVID-19 vaccination in China: adverse effects and its impact on health care working decisions on booster dose. Nato Adv Sci Inst Se. 2022;10(8):1–11. doi:10.3390/vaccines10081229.
   Google Scholar
• Tung TH, Lin XQ, Chen Y, Zhang MX, Zhu JS. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccines Immunother. 2022;18(6):1–7. doi:10.1080/21645515.2021.2014731.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A. et al. Factors associated with COVID-19 vaccine booster hesitancy: a retrospective cohort study, fukushima vaccination community survey. Nato Adv Sci Inst Se. 2022;10(4):4–11. doi:10.3390/vaccines10040515.
   Google Scholar
• Folcarelli L, Del Giudice GM, Corea F, Angelillo IF. Intention to receive the COVID-19 vaccine booster dose in a university community in Italy. Nato Adv Sci Inst Se. 2022;10(2):1–11. doi:10.3390/vaccines10020146.
   Google Scholar
• Lee RC, Hu H, Kawaguchi ES, Kim AE, Soto DW, Shanker K, Klausner JD, Van Orman S, Unger JB. COVID-19 booster vaccine attitudes and behaviors among university students and staff in the United States: The USC trojan pandemic research initiative. Prev Med Rep. 2022;28(June):101866. doi:10.1016/j.pmedr.2022.101866.
   PubMedGoogle Scholar
• Storph RP, Essuman MA, Duku‐Takyi R, Akotua A, Asante S, Armah R, Donkoh IE, Addo PA. Willingness to receive COVID-19 booster dose and its associated factors in Ghana: A cross-sectional study. Health Sci Rep. 2023;6(4). doi:10.1002/hsr2.1203.
   PubMedGoogle Scholar
• Lounis M, Bencherit D, Rais MA, Riad A. COVID-19 Vaccine Booster Hesitancy (VBH) and its drivers in Algeria: national cross-sectional survey-based study. Nato Adv Sci Inst Se. 2022;10(4):1–14. doi:10.3390/vaccines10040621.
   Google Scholar
• Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult americans: A cross-sectional study. Nato Adv Sci Inst Se. 2021;9(12):1424. doi:10.3390/vaccines9121424.
   Google Scholar
• Pal S, Shekhar R, Kottewar S, Upadhyay S, Singh M, and Pathak D, “Pal S, Shekhar R, Kottewar S, Upadhyay S, Singh M, Pathak D. et al. COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers. Vaccines. 2021 Nov 19;9(11):1358. Mdpi, pp. 1–11, 2021.10.3390/vaccines9111358.
   PubMed Web of Science ®Google Scholar
• Sugawara N, Yasui-Furukori N, Fukushima A, Shimoda K. Attitudes of medical students toward COVID-19 vaccination: Who is willing to receive a third dose of the vaccine? Vaccines. 2021;9(11):1–0. doi:10.3390/vaccines9111295.
   Web of Science ®Google Scholar
• Lubad MA, Abu-Helalah MA, Alahmad IF, Al-Tamimi MM, QawaQzeh MS, Al-Kharabsheh AM, Alzoubi H, Alnawafleh AH, Kheirallah KA. Willingness of healthcare workers to recommend or receive a third COVID-19 vaccine dose: a cross-sectional study from Jordan. Infect Dis Rep. 2023;15(2):210–21. doi:10.3390/idr15020022.
   PubMed Web of Science ®Google Scholar
• Tao C, Lim X, Chew C, Rajan P, Chan H. Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country. Vaccine. 2020;40(January):7515–7519.
   Google Scholar
• Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, Mizrahi B, Alroy-Preis S, Ash N, Milo R. et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393–400. doi:10.1056/nejmoa2114255.
   PubMed Web of Science ®Google Scholar
• Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D, Yaron S. BNT162b2 vaccine booster and mortality due to Covid-19. N Engl J Med. 2021;385(26):2413–20. doi:10.1056/nejmoa2115624.
   PubMed Web of Science ®Google Scholar
• Mohamed NA, Solehan HM, Dzulkhairi M, Rani M. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web- based survey. PLOS ONE. 2021;16(8):1–17. doi:10.1371/journal.pone.0256110.
   Web of Science ®Google Scholar
• Ssentongo ESH, Paddy AES, Ba DM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta- analysis. PloS Negl Trop Dis. 2020;15(8):1–16. doi:10.1371/journal.pone.0238215.
   Google Scholar
• Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster covid‐19 vaccine dose in poland. Nato Adv Sci Inst Se. 2021;9(11):1–14. doi:10.3390/vaccines9111286.
   Google Scholar
• Chan EY, Cheng CK, Tam GC, Huang Z, Lee PY. Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional study of Hong Kong community. Vaccine. 2015;33(38):4737–40. doi:10.1016/j.vaccine.2015.07.046.
   PubMed Web of Science ®Google Scholar
• Banik R, Rahman M, Sikder MT, Rahman QM, Pranta MUR. Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis. J Public Heal Theory Pract. 2021;31(1):9–19. doi:10.1007/s10389-020-01432-7.
   Google Scholar
• Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines MDPI. 2020;8(482):1–14. doi:10.3390/vaccines8030482.
   Google Scholar
• Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, Zhang H, Feng H, Guo J, Fang H. et al. Public perceptions and acceptance of COVID-19 booster vaccination in China: a cross-sectional study. Vaccines MDPI. 2021;9(1461):1–17. doi:10.3390/vaccines9121461.
   Google Scholar